Search Results for: u.s. stem cell

Today, I am launching a new effort called Stem Cell Outreach Program for Education  (SCOPE). I think stem cell technology will transform medicine across the globe, but it will take a concerted effort to make certain that stem cell-based therapies do not become a type of medicine only available to the relatively wealthy or predominantly available […]

There has been a lot of publicity about the reported stem cell treatment of NY Yankees pitcher Bartolo Colon.  According to several sources, Colon received his treatment in his native Dominican Republic. Major League Baseball reportedly seems most concerned about this case, at least publicly, because human growth hormone (hGH) might have been used in

Last week I posted a stem cell treatment poll. I was curious about people’s experiences and attitudes toward non-FDA approved stem cell treatments. During my time as a stem cell scientist and educator, I have met many people, some of whom have told me about their experiences with stem cell treatments. The results of the

In the debate over funding for embryonic stem cell research, it is usually assumed that Democrats are in favor of embryonic stem cell research and that Republicans are opposed. But recent polls suggest that amongst the U.S. population as a whole, most political and religious groups are widely in favor of embryonic stem cell research.

This past week was a wacky and wild one for the stem cell field. All kinds of crazy things happened all in one week. What does it all mean? Stem cells the new steroids for sports? Reports surface this week that NY Yankees pitcher Bartolo Colon, had received a non-FDA approved stem cell treatment for

Ideas are the foundation of stem cell research, but funding makes those ideas a reality. We talk a lot about governmental funding of stem cell research through CIRM and NIH. The funding from these agencies is essential and will undoubtedly lead to new treatments and cures, possibly for millions of patients. But there is another

It seems reasonably likely that in the end, the final say on the embryonic stem cell case one way or another will be decided by the U.S. Supreme Court. While yesterday brought a victory for science and patients and logic, this was just one battle, not the war. The war that opponents of ES cell

Who’s who in the iPS cell field?  In this post, I examine the people, journals, places, funding agencies, and companies that are the leaders in the iPS cell field. I start with publishing. Last year we did a post on publishing trends in the iPS cell field.  It suggested that the iPS cell field was exploding

How are things looking for the stem cell field for Spring 2011? Issue One. Getting to the clinic. At this point, Geron and ACT have their FDA-approved clinical trials underway using derivatives of human embryonic stem cells. As expected no news has leaked out on how things are going and it may well be Fall